USA Shipped · Chino, California
CoreVials.com Research Peptides
Shop Autoship GLP Plans Blog Contact
Sign In
Research Use Only Products are for laboratory research only, not for human or animal consumption. Research Compliance
Research Reference

Cagrilintide + Semaglutide Research Reference

Complete research reference and reconstitution guide for Cagrilintide + Semaglutide.

Research Use Only Reconstitution Math Storage Reference

Quick Reference

Vial Amount
5mg
CoreVials Standard Mix
Add 3 mL (300 units) BAC Water
Final Concentration
1.67 mg/mL
Easy Reference
10 units = 0.50 mg total
Storage
Refrigerate after reconstitution

This page is for research-use-only educational reference and measurement math. It is not medical, veterinary, dosing, administration, or treatment guidance. Products are not for human or animal consumption.

On this page

How This Works

Cagrilintide is a long‑acting amylin analog that reduces appetite via central satiety pathways, while Semaglutide activates GLP‑1 receptors to enhance glucose‑dependent insulin secretion and suppress glucagon[4][5]. The combination leverages complementary mechanisms: amylin primarily delays gastric emptying and signals satiety through the area postrema, while GLP‑1 enhances pancreatic β‑cell function and central appetite suppression[1]. Clinical trials of the co‑prepared regimen (CagriSema) show greater body‑weight reduction than either agent alone[2].

CoreVials Standard Mix

For a 5mg vial Add 3 mL (300 units) BAC Water
Final concentration 1.67 mg/mL

After mixing (U-100 syringe reference)

  • 5 units=0.25 mg
  • 10 units=0.50 mg total
  • 20 units=1 mg

These are example measurement calculations only. They are not dosing, administration, medical, or veterinary guidance.

Other Mix Options
BAC Added Final Concentration 5 units equals 10 units equals
3 mL (300 units) CoreVials Standard Mix 1.67 mg/mL 0.25 mg 0.50 mg total

Supply Planning

Products commonly paired for research preparation:

  • Cagrilintide + Semaglutide Research Reference
  • BAC Water
  • Cryo labels
  • Storage case
Shop Peptides View BAC Water

References

Lancet Diabetes Endocrinology (2024)
— Efficacy and safety of co‑prepared once‑weekly cagrilintide 2.4 mg with Semaglutide 2.4 mg in type 2 diabetes: phase 2 trial

Lancet (2021)
— Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant cagrilintide with Semaglutide 2.4 mg: phase 1b trial

Lancet (2021)
— Once‑weekly cagrilintide for weight management: dose‑finding phase 2 trial in overweight/obesity

StatPearls (2025)
— Semaglutide: pharmacology, indications, and clinical use overview

Cureus (2024)
— Semaglutide: risks and benefits review (PMC)

WHO (2010)
— Best practices for measurement and related procedures (WHO toolkit)

Sigma‑Aldrich (2016)
— Peptide Handling Guide: storage, reconstitution, and stability

View Source

LibreTexts (2020)
— Intradermal and measurements: clinical procedures

CDC (2024)
— Vaccine preparation: handling reference

PubMed (2024)
— Cagrilintide‑Semaglutide in adults with overweight/obesity and type 2 diabetes

ScienceDirect (2024)
— Efficacy and safety of CagriSema 2.4 mg + 2.4 mg in type 2 diabetes

PMC (2019)
— drug measurement: pharmacologic review

Research Use Notice

This page is research-use-only educational reference and measurement math. It is not medical, veterinary, dosing, administration, or treatment guidance. Products are not for human or animal consumption.

Need research supplies?

High-purity peptides and lab essentials with batch-level COA transparency.

Shop Peptides View BAC Water

Related Protocols

Research Use Only Products are for laboratory research only, not for human or animal consumption. Research Compliance